4,5 It was a relatively small trial as the primary objective of the trial was to confirm that treatment with oral semaglutide does not result in an unacceptable increase in cardiovascular risk compared with placebo in patients with a high risk of cardiovascular events
The most commonly reported adverse effects of Wegovy include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal discomfort Injection site reactions : redness, itching, or mild swelling at the injection site Fatigue or headache in some individuals These side effects are generally mild to moderate and tend to diminish as the body adjusts to the medication, particularly during the gradual dose-escalation schedule designed to improve tolerability
Utilization management controls that incorporate comprehensive management inclusive of lifestyle, activity, and diet allowing for tapering of drug
As Roslin mentioned, its not as simple as one answer